Summary
Forte Biosciences shares surge after argenx agrees to acquire company for $2.2B
Forte Biosciences (NASDAQ:FBRX) shares surged about 40% to around $76 on Monday after argenx (NASDAQ:ARGX) announced an agreement to acquire the biotechnology company in a deal valued at approximately $2.2 billion. Under the terms of the agreement, argenx will acquire all outstanding Forte Biosciences shares for $77 per share in cash.
FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data
Forte Biosciences stock soars after early-stage data show FB102 significantly improves facial depigmentation in vitiligo with a favorable safety profile.
Forte Biosciences' FB102 Hits Key Goal in Vitiligo Study, Shows Durable Improvement
Forte Biosciences NASDAQ: FBRX said FB102 showed statistically significant improvement in a small placebo-controlled vitiligo study, with Chief Executive Officer Paul Wagner highlighting continued improvement after patients stopped treatment as a key feature of the results.
Forte Biosciences, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| NA Nizar Araji National Bank Of Canada /FI/ | 572 | $14,488.4 | $44,038.28 | $29,549.88 | 203.96% |
| KM Kristin Mariani Janus Henderson Group PLC | 1.43M | $14.34M | $109.77M | $95.43M | 665.47% |
| CD Charlie Durham Sterling Capital Management LLC | 68 | $1,445 | $5,235.32 | $3,790.32 | 262.31% |
 Joseph Castro Nuveen LLC | 108,347 | $2.3M | $8.34M | $6.04M | 262.31% |
 Li Peng China Universal Asset Management Co. Ltd. | 8,000 | $170,560 | $615,920 | $445,360 | 261.12% |
Forte Biosciences, Inc. (FBRX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Forte Biosciences, Inc. ever had a stock split?
Forte Biosciences, Inc. Profile
| Biotechnology Industry | Healthcare Sector | Paul A. Wagner CEO | NASDAQ (CM) Exchange | 34962G208 CUSIP |
| US Country | 23 Employees | 16 Jun 2020 Last Dividend | 28 Aug 2024 Last Split | - IPO Date |
Contact Information
